Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Phase 2 Trial

Recent news which mentions Phase 2 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
Clene Nanomedicine Presents Updated Data From Mid-Stage Amyotrophic Lateral Sclerosis Trials
Tickers CLNN
Tags News General Penny Stocks
From Benzinga
BridgeBio Pharma Posts Updated Data From Muscular Dystrophy Trial, Plots Path To Market
Tickers BBIO
Tags BBIO Briefs Small Cap
From Benzinga
Scholar Rock To Highlight Apitegromab Data From Ambulatory Cohort In Muscular Dystrophy
Tickers SRRK
Tags Small Cap Spinal Muscular Atrophy Briefs
From Benzinga
Why Sanofi Shares Are Trading Lower Today
Tickers SNY
Tags breast cancer Health Care Trading Ideas
From Benzinga
Moderna Starts Dosing In Mid-Stage Omicron-Specific Bivalent Booster Candidate
Tickers MRNA
Tags Market News COVID/19 Coronavirus Phase 2 Trial
From Benzinga
FDA Gives Green Signal To Inventiva's Mid-Stage Lanifibranor Study In NASH Patients
Tickers IVA
Tags Small Cap Briefs Biotech
From Benzinga
Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer
Tickers ALKS
Tags renal cell carcinoma Briefs Movers
From Benzinga
Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer
Tickers AMGN
Tags Briefs AMGN Market News
From Benzinga
ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting
Tickers ENDP IBRX MRK
Tags Benzinga General why it's moving
From Benzinga
BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer
Tickers BTAI MRK
Tags Briefs BTAI Small Cap
From Benzinga
Opthea Shares OPT-302 data In Patients With Subtype Of Age-Related Macular Degeneration
Tickers OPT
Tags Biotech Phase 2 Trial Market News
From Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
Tickers RGNX
Tags General gene therapy Benzinga
From Benzinga
4D Molecular Shares Updated Data From Fabry Disease Trial
Tickers FDMT
Tags Movers Market News Small Cap
From Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
Tickers AVRO
Tags Market News Biotech Phase 2 Trial
From Benzinga
Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday?
Tickers NLSP
Tags Movers Market News Briefs
From Benzinga
Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward
Tickers PFE VALN
Tags VALN Health Care Benzinga
From Benzinga
Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity
Tickers ALT
Tags Market News Movers obesity
From Benzinga
Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target
Tickers JNJ KLDO
Tags Analyst Ratings General Benzinga
From Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
Tickers TSHA
Tags Market News Movers Briefs
From Benzinga
4D Pharma's Asthma Candidate Shows Positive Trends In Multiple Secondary Endpoints Of Efficacy
Tickers LBPS
Tags Briefs Movers Market News
From Benzinga
Why Are Tyme Technologies Shares Staring At 52-Week Low
Tickers TYME
Tags Phase 2 Trial Biotech TYME
From Benzinga
Two Organizations To Support Wave Life Sciences' FTD, ALS Program
Tickers WVE
Tags Briefs Biotech Phase 2 Trial
From Benzinga
Imara To Start Testing Tovinontrine In Heart Failure Patients
Tickers IMRA
Tags Trading Ideas News Penny Stocks
From Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
Tickers FBIO MBIO
Tags Phase 2 Trial FDA Biotech
From Benzinga
89bio's NASH Candidate Shows Improvement In Disease Severity, Cardiovascular Health
Tickers ETNB
Tags Non Alcoholic steatohepatitis General News
From Benzinga
Tango Therapeutics' TNG908 IND For Cancer Study Gets Green Signal By FDA
Tickers TNGX
Tags TNGX Phase 2 Trial Biotech
From Benzinga
On Positive Virology Data, SAB Biotherapeutics' COVID-19 Drug To Move To Phase 3 In NIH ACTIV-2 Trial
Tickers SABS
Tags Phase 3 Trial Biotech Phase 2 Trial
From Benzinga
MediWound's EscharEx Mid-Stage Trial Meets Primary Goal In Venous Leg Ulcers
Tickers MDWD
Tags Market News Phase 2 Trial Briefs
From Benzinga
Mirati Therapeutics Posts 41% Objective Response Rate In Pretreated GI Cancer Patients
Tickers MRTX
Tags Benzinga MRTX Health Care
From Benzinga
Provention Bio Starts Mid-Stage Lupus Trial; Data Expected In 2024
Tickers PRVB
Tags Health Care Benzinga Systemic Lupus Erythematosus
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.